+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurostimulation Devices Global Market Report 2024

  • PDF Icon

    Report

  • 250 Pages
  • November 2023
  • Region: Global
  • The Business Research Company
  • ID: 5733989
The neurostimulation devices market size has grown rapidly in recent years. It will grow from $6.34 billion in 2023 to $6.98 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth observed during the historic period in the field of neurostimulation devices can be attributed to several key factors, including the increasing need for chronic pain management, the aging population, greater awareness and acceptance of these devices as treatment options, and the adoption of a multidisciplinary approach to managing various medical conditions.

The neurostimulation devices market size is expected to see strong growth in the next few years. It will grow to $10.12 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The expected growth in the forecast period in the field of neurostimulation devices can be attributed to various factors, including the adoption of minimally invasive techniques, the expansion of emerging markets, regulatory support and reimbursement initiatives, and the integration of telehealth and remote monitoring in patient care. Noteworthy trends anticipated during the forecast period encompass the development of personalized therapy approaches, the emergence of wearable neurostimulation devices, advancements in programming and connectivity features, and the exploration of combination therapies to enhance treatment outcomes.

The increasing global geriatric population is a significant driver behind the growth of the neurostimulation device market. As the number of elderly individuals continues to rise, so does the prevalence of various neurobiological disorders affecting this demographic. According to a report by the World Health Organization (WHO) in October 2022, it is projected that by 2050, 80% of older people will reside in low- and middle-income countries. Furthermore, the proportion of the world's population over the age of 60 is expected to nearly double from 12% in 2015 to 22% in 2050.

The primary products in the neurostimulation devices market can be categorized into implantable devices and external devices. Implantable devices include cochlear implants, deep brain stimulation devices, spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and gastric electric stimulation devices. External devices encompass transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). These devices are used in a variety of applications, including pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, and Parkinson's disease. They are employed by different healthcare facilities, such as hospitals, rehabilitation centers, and medical clinics.

The neurostimulation device market research report is one of a series of new reports that provides neurostimulation device market statistics, including neurostimulation device industry global market size, regional shares, competitors with a neurostimulation device market share, detailed neurostimulation device market segments, market trends and opportunities, and any further data you may need to thrive in the neurostimulation device industry. This neurostimulation device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anticipated growth in the healthcare sector is set to propel the neurostimulation devices market. The healthcare industry is a vast and diverse sector encompassing various organizations, professionals, and institutions dedicated to providing medical services, healthcare products, and overall health maintenance and improvement. Neurostimulation devices play a crucial role in the healthcare industry, particularly in the treatment and management of various neurological conditions and chronic pain. For example, in May 2023, the Office for National Statistics reported that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021. The total healthcare expenditure in the UK in 2021 amounted to $367.25 billion (£280.7 billion), with pharmaceutical expenditure reaching $51.84 billion (£39.6 billion). Spending on preventive care also doubled from 2020, reaching $45.93 billion (£35.1 billion). Thus, the burgeoning healthcare industry is a driving force behind the growth of the neurostimulation devices market.

The high costs associated with neurostimulation devices may hinder market growth. For instance, neuromodulation devices for chronic pain management have an average price range of $13,920 to $17,940, while those for epilepsy range from $25,420 to $25,970. Although the construction of neurostimulation devices is similar to cardiac rhythm management devices, they are notably 67% more expensive than the latter.

Innovations in minimally invasive treatments for various neurological disorders are emerging, leading to the development of neurostimulation devices that cause minimal invasion during procedures. For example, Deep Brain Stimulation (DBS) is a minimally invasive surgical procedure used to treat neurological symptoms of Parkinson's disease. DBS involves the use of a neurostimulation device, similar to a heart pacemaker, to deliver precise electrical pulses to specific brain circuits that influence Parkinson's disease symptoms. These electrical pulses block the activity of these circuits, allowing the rest of the brain to function more normally.

Major companies in the neurostimulation devices market are focused on developing advanced technological products like the Eterna Spinal Cord Stimulation (SCS) system for chronic pain treatment. The Eterna SCS system, launched by Abbott Laboratories in December 2022, is the smallest implantable, rechargeable spinal cord stimulator. It features Abbott's proprietary BurstDR stimulation, which replicates natural firing patterns in the brain, providing superior pain relief preferred by 87% of patients over traditional 'tingling' tonic stimulation.

In June 2022, Medtronic plc., an Ireland-based medical device company, acquired Intersect ENT to expand its comprehensive ear, nose, and throat (ENT) portfolio. This acquisition enhances Medtronic's offerings for sinus procedures to improve post-operative outcomes and treat nasal polyps. Intersect ENT is a US-based company specializing in healthcare equipment.

Major companies operating in the neurostimulation devices market include Medtronic PLC, Cyberonics Inc., Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., Cochlear Ltd., NDI Medical LLC, Synapse Biomedical Inc., MED-EL, LivaNova PLC, DePuy Synthes Inc., Aleva Neurotherapeutics, BrainsWay, Cortec Corporation, Endonovo Therapeutics Inc., Inspire Medical Systems Inc., The Magstim Company Limited, Mainstay Medical Limited, MicroTransponder Inc., MindMaze, NeuroMetrix, Nexeon MedSystems, Nuvectra, Saluda Medical, SPR Therapeutics Inc., Uro Medical Corporation

North America was the largest region in the global neurostimulation devices market in 2023. Asia-Pacific was the second-largest region in the neurostimulation devices market. The regions covered in the neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The neurostimulation devices market consists of sales of spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Neurostimulation Devices Market Characteristics3. Neurostimulation Devices Market Trends And Strategies
4. Neurostimulation Devices Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Neurostimulation Devices Market Size and Growth
5.1. Global Neurostimulation Devices Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Neurostimulation Devices Historic Market Size and Growth, 2018 2023, Value ($ Billion)
5.3. Global Neurostimulation Devices Forecast Market Size and Growth, 2023 2028, 2033F, Value ($ Billion)
6. Neurostimulation Devices Market Segmentation
6.1. Global Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Implantable Devices
  • External Devices
6.2. Global Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
6.3. Global Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Rehabilitation Centers
  • Medical Clinics
7. Neurostimulation Devices Market Regional And Country Analysis
7.1. Global Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Neurostimulation Devices Market
8.1. Asia-Pacific Neurostimulation Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Neurostimulation Devices Market
9.1. China Neurostimulation Devices Market Overview
9.2. China Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Neurostimulation Devices Market
10.1. India Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Neurostimulation Devices Market
11.1. Japan Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Neurostimulation Devices Market
12.1. Australia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Neurostimulation Devices Market
13.1. Indonesia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Neurostimulation Devices Market
14.1. South Korea Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Neurostimulation Devices Market
15.1. Western Europe Neurostimulation Devices Market Overview
15.2. Western Europe Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Neurostimulation Devices Market
16.1. UK Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Neurostimulation Devices Market
17.1. Germany Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Neurostimulation Devices Market
18.5. France Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Neurostimulation Devices Market
19.9. Italy Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Neurostimulation Devices Market
20.13. Spain Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Neurostimulation Devices Market
21.1. Eastern Europe Neurostimulation Devices Market Overview
21.2. Eastern Europe Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Neurostimulation Devices Market
22.1. Russia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Neurostimulation Devices Market
23.1. North America Neurostimulation Devices Market Overview
23.2. North America Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Neurostimulation Devices Market
24.1. USA Neurostimulation Devices Market Overview
24.2. USA Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Neurostimulation Devices Market
25.1. Canada Neurostimulation Devices Market Overview
25.2. Canada Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Neurostimulation Devices Market
26.1. South America Neurostimulation Devices Market Overview
26.2. South America Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Neurostimulation Devices Market
27.1. Brazil Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Neurostimulation Devices Market
28.1. Middle East Neurostimulation Devices Market Overview
28.2. Middle East Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Neurostimulation Devices Market
29.1. Africa Neurostimulation Devices Market Overview
29.2. Africa Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Neurostimulation Devices Market Competitive Landscape And Company Profiles
30.1. Neurostimulation Devices Market Competitive Landscape
30.2. Neurostimulation Devices Market Company Profiles
30.2.1. Medical Clinics
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Medtronic plc
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Cyberonics Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Boston Scientific Corporation
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Abbott Laboratories
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Neurostimulation Devices Market Competitive Benchmarking32. Global Neurostimulation Devices Market Competitive Dashboard33. Key Mergers And Acquisitions In The Neurostimulation Devices Market
34. Neurostimulation Devices Market Future Outlook and Potential Analysis
34.1 Neurostimulation Devices Market In 2028 - Countries Offering Most New Opportunities
34.2 Neurostimulation Devices Market In 2028 - Segments Offering Most New Opportunities
34.3 Neurostimulation Devices Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Executive Summary

Neurostimulation Devices Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for neurostimulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

  • Markets Covered: 1) By Product: Implantable Devices; External Devices; 2) By Application: Pain Management; Epilepsy; Essential Tremor; Urinary and Fecal Incontinence; Depression; Dystonia; Gastroparesis; Parkinson's Disease; 3) By End User: Hospitals; Rehabilitation Centers; Medical Clinic
Sub-Segments Covered:

By Implantable Devices: Cochlear Implants; Deep Brain Stimulation; Spinal Cord Stimulation; Vagus Nerve Stimulation; Sacral Nerve Stimulation; Gastric Electric Stimulation 5) By External Devices: Transcranial Magnetic Stimulation (TMS); Transcutaneous Electrical Nerve Stimulation (TENS)
  • Companies Mentioned: Medtronic plc; Cyberonics Inc.; Boston Scientific Corporation; Abbott Laboratories; Nevro Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic plc
  • Cyberonics Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Nevro Corporation
  • Neuronetics Inc.
  • NeuroPace Inc.
  • NeuroSigma Inc.
  • Cochlear Ltd.
  • NDI Medical LLC
  • Synapse Biomedical Inc.
  • MED-EL
  • LivaNova PLC
  • DePuy Synthes Inc.
  • Aleva Neurotherapeutics
  • BrainsWay
  • Cortec Corporation
  • Endonovo Therapeutics Inc.
  • Inspire Medical Systems Inc.
  • The Magstim Company Limited
  • Mainstay Medical Limited
  • MicroTransponder Inc.
  • MindMaze
  • NeuroMetrix
  • Nexeon MedSystems
  • Nuvectra
  • Saluda Medical
  • SPR Therapeutics Inc.
  • Uro Medical Corporation

Methodology

Loading
LOADING...